The measurement of polyglutamate metabolites of the thymidylate synthase inhibitoR, ICI D1694, in mouse and human cultured cells
- 1 February 1993
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 45 (4) , 863-869
- https://doi.org/10.1016/0006-2952(93)90170-2
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- The biochemical pharmacology of the thymidylate synthase inhibitor, 2-desamino-2-methyl-N10-propargyl-5,8-dideazafolic acid (ICI 198583)Biochemical Pharmacology, 1991
- Structural features of 5,10-dideaza-5,6,7,8-tetrahydrofolate that determine inhibition of mammalian glycinamide ribonucleotide formyltransferaseBiochemistry, 1991
- Thymidylate synthase inhibitors: The in vitro activity of a series of heterocyclic benzoyl ring modified 2-desamino-2-methyl-N10-substituted-5,8-dideazafolatesAdvances in Enzyme Regulation, 1991
- Folylpolyglutamate Synthesis and Role in the Regulation of One-Carbon MetabolismPublished by Elsevier ,1989
- Formation and retention and biological activity of N10-propargyl-5, 8-dideazafolic acid (CB3717) polyglutamates in L1210 cells in vitroBiochemical Pharmacology, 1988
- Polyglutamation of methotrexate. Is methotrexate a prodrug?Journal of Clinical Investigation, 1985
- The clinical pharmacokinetics of the novel antifolate N10-propargyl-5,8-dideazafolic acid (CB 3717)Cancer Chemotherapy and Pharmacology, 1985
- Intracellular pharmacokinetics of methotrexate polyglutamates in human breast cancer cells. Selective retention and less dissociable binding of 4-NH2-10-CH3-pteroylglutamate4 and 4-NH2-10-CH3-pteroylglutamate5 to dihydrofolate reductase.Journal of Clinical Investigation, 1983
- Synthesis, Retention, and Biological Activity of Methotrexate Polyglutamates in Cultured Human Breast Cancer CellsJournal of Clinical Investigation, 1982
- Human thymidylate synthetase—IIIBiochemical Pharmacology, 1979